Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BSI SA

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 4
Rounds per year 0.03
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 2
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Genetics
  • Medical
Summary

BSI SA is the famous Corporate Investor, which was founded in 1873. The fund was located in Europe if to be more exact in Switzerland. The main office of represented Corporate Investor is situated in the Lugano.

Opposing the other organizations, this BSI SA works on 11 percentage points more the average amount of lead investments. The important activity for fund was in 2010. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2016.

Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Perlegen Sciences, VisionCare Ophthalmic Technologies, GlobeImmune.

The typical case for the fund is to invest in rounds with 4 participants. Despite the BSI SA, startups are often financed by Three Arch Partners, Pitango Venture Capital, ONSET Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, Saints Capital, ProQuest Investments. In the next rounds fund is usually obtained by ProQuest Investments, Aravis Ventures, SternAegis Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BSI SA:
Typical Co-investors
BSI SA is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BSI SA:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
0 Ventures New York, New York, United States
Akers Capital California, Fair Oaks, United States
Alma Mater Society British Columbia, Canada, Vancouver
Bo Nian Kang Health Management Group -
Ecosia Berlin, Berlin, Germany
Loeb Enterprises New York, New York, United States
Renewable Energy Venture Capital -
Taishin International Bank Taipei, Taiwan
Tiempo France, Montbonnot-saint-martin, Rhone-Alpes
United Technologies Connecticut, Hartford, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Telormedix

Biopharma
Biotechnology
Health Care
Therapeutics
$19M30 Sep 2008 Ticino, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BSI SA?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 38M
Rounds per year 0.03
Peak activity year 2010
Lead investments 0
Follow on index 0.20
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Telormedix

Biopharma
Biotechnology
Health Care
Therapeutics
$19M30 Sep 2008 Ticino, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: